A reduction of serum Cp level in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis patients further supports the hypothesis that Cp might play a role in the liver/AT cross‐talk and in lipid homeostasis [49, 50, 51, 52]. Here, CP is linked to metabolic dysfunction-associated steatotic liver disease.